The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Methylprednisolone sodium hemisuccinate     sodium4-[2- [(6S,8R,9R,10S,11S,13S,14S...

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.





Chemical compound and disease context of METHYLPREDNISOLONE HEMISUCCINATE






Associations of METHYLPREDNISOLONE HEMISUCCINATE with other chemical compounds




Analytical, diagnostic and therapeutic context of METHYLPREDNISOLONE HEMISUCCINATE


  1. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. Bone, R.C., Fisher, C.J., Clemmer, T.P., Slotman, G.J., Metz, C.A., Balk, R.A. N. Engl. J. Med. (1987) [Pubmed]
  2. Complete resolution of pure red cell aplasia in a patient with chronic lymphocytic leukemia following antithymocyte globulin therapy. Radosevich, C.A., Gordon, L.I., Weil, S.C., Marder, R.J., Rosen, S.T. JAMA (1988) [Pubmed]
  3. Cardiac transplantation in an 8-month-old female infant with subendocardial fibroelastosis. Cooley, D.A., Frazier, O.H., Van Buren, C.T., Bricker, J.T., Radovancevic, B. JAMA (1986) [Pubmed]
  4. Electrocardiographic precordial mapping in anterior myocardial infarction. The critical period for interventions as exemplified by methylprednisolone. Selwyn, A.P., Fox, K.M., Welman, E., Jonathan, A., Shillingford, J.P. Circulation (1978) [Pubmed]
  5. Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog. Vogel, W.M., Zannoni, V.G., Abrams, G.D., Lucchesi, B.R. Circulation (1977) [Pubmed]
  6. Effects of pulse methylprednisolone on cell adhesion molecules in the synovial membrane in rheumatoid arthritis. Reduced E-selectin and intercellular adhesion molecule 1 expression. Youssef, P.P., Triantafillou, S., Parker, A., Coleman, M., Roberts-Thomson, P.J., Ahern, M.J., Smith, M.D. Arthritis Rheum. (1996) [Pubmed]
  7. Cardiopulmonary adjustments following single high dosage administration of methylprednisolone in traumatized man. Lozman, J., Dutton, R.E., English, M., Powers, S.R. Ann. Surg. (1975) [Pubmed]
  8. Effectiveness of steroid/antibiotic treatment in primates administered LD100 Escherichia coli. Hinshaw, L.B., Beller-Todd, B.K., Archer, L.T., Benjamin, B., Flournoy, D.J., Passey, R., Wilson, M.F. Ann. Surg. (1981) [Pubmed]
  9. Experimental herpes simplex virus encephalitis. Effect of corticosteroids and pyrimidine nucleoside. Baringer, J.R., Klassen, T., Grumm, F. Arch. Neurol. (1976) [Pubmed]
  10. Glutathione monoethyl ester improves functional recovery, enhances neuron survival, and stabilizes spinal cord blood flow after spinal cord injury in rats. Guízar-Sahagún, G., Ibarra, A., Espitia, A., Martínez, A., Madrazo, I., Franco-Bourland, R.E. Neuroscience (2005) [Pubmed]
  11. Pharmacokinetics of methylprednisolone succinate, methylprednisolone, and lidocaine in the normal dog and during hemorrhagic shock. Toutain, P.L., Autefage, A., Oukessou, M., Alvinerie, M. Journal of pharmaceutical sciences. (1987) [Pubmed]
  12. Inhibition of antigen-induced bronchoconstriction by methylprednisolone succinate. Delehunt, J.C., Yerger, L., Ahmed, T., Abraham, W.M. J. Allergy Clin. Immunol. (1984) [Pubmed]
  13. Morphological aspects of glucocorticoid-induced cell death in human lymphoblastoid cells. Robertson, A.M., Bird, C.C., Waddell, A.W., Currie, A.R. J. Pathol. (1978) [Pubmed]
  14. Steroids inhibit activation of the alternative-amplification pathway of complement. Packard, B.D., Weiler, J.M. Infect. Immun. (1983) [Pubmed]
  15. Attenuation of progressive brain hypoperfusion following experimental subarachnoid hemorrhage by large intravenous doses of methylprednisolone. Hall, E.D., Travis, M.A. Exp. Neurol. (1988) [Pubmed]
  16. Phenytoin, methylprednisolone sodium succinate and graft survival. Speier, S., Bromberg, J.M., Lempert, N. J. Pharmacol. Exp. Ther. (1981) [Pubmed]
  17. Neutrophil trafficking into inflamed joints in patients with rheumatoid arthritis, and the effects of methylprednisolone. Youssef, P.P., Cormack, J., Evill, C.A., Peter, D.T., Roberts-Thomson, P.J., Ahern, M.J., Smith, M.D. Arthritis Rheum. (1996) [Pubmed]
  18. Treatment of acute obstructive renal failure with high-dose methylprednisolone. Flombaum, C.D., Schroy, P., Watson, R., Vanamee, P. Arch. Intern. Med. (1986) [Pubmed]
  19. Protective effect of methylprednisolone sodium succinate on the ultrastructure and resting tension of hypoxic heart muscle. Nayler, W.G., Yepez, C., Grau, A., Slade, A. Cardiovasc. Res. (1978) [Pubmed]
  20. Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy. Elovaara, I., Ukkonen, M., Leppäkynnäs, M., Lehtimäki, T., Luomala, M., Peltola, J., Dastidar, P. Arch. Neurol. (2000) [Pubmed]
  21. Efficacy of methylprednisolone therapy for the injured rat spinal cord. Rabchevsky, A.G., Fugaccia, I., Sullivan, P.G., Blades, D.A., Scheff, S.W. J. Neurosci. Res. (2002) [Pubmed]
  22. Is intravenous glucocorticoid therapy better than an oral regimen for asymptomatic cardiac rejection? A randomized trial. Kobashigawa, J.A., Stevenson, L.W., Moriguchi, J.D., Kawata, N., Brownfield, E., Drinkwater, D.C., Laks, H. J. Am. Coll. Cardiol. (1993) [Pubmed]
  23. Immediate inhibitory effect of methylprednisolone suleptanate (U-67590A) on antigen-induced cutaneous and airway anaphylactic responses in guinea-pigs. Hashimoto, M., Shinozaki, Y., Katori, M. Br. J. Pharmacol. (1993) [Pubmed]
  24. Evaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injury. Braughler, J.M., Hall, E.D., Means, E.D., Waters, T.R., Anderson, D.K. J. Neurosurg. (1987) [Pubmed]
  25. Pharmacokinetics of methylprednisolone, methylprednisolone sodium succinate, and methylprednisolone acetate in dogs. Toutain, P.L., Koritz, G.D., Fayolle, P.M., Alvinerie, M. Journal of pharmaceutical sciences. (1986) [Pubmed]
  26. The effect of bulking agent on the solid-state stability of freeze-dried methylprednisolone sodium succinate. Herman, B.D., Sinclair, B.D., Milton, N., Nail, S.L. Pharm. Res. (1994) [Pubmed]
  27. The effects of pulse methylprednisolone on matrix metalloproteinase and tissue inhibitor of metalloproteinase-1 expression in rheumatoid arthritis. Wong, P., Cuello, C., Bertouch, J.V., Roberts-Thomson, P.J., Ahern, M.J., Smith, M.D., Youssef, P.P. Rheumatology (Oxford, England) (2000) [Pubmed]
  28. Glucocorticoid-mediated regulation of utrophin levels in human muscle fibers. Courdier-Fruh, I., Barman, L., Briguet, A., Meier, T. Neuromuscul. Disord. (2002) [Pubmed]
  29. Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. Kaptanoglu, E., Solaroglu, I., Okutan, O., Surucu, H.S., Akbiyik, F., Beskonakli, E. Neurosurgical review. (2004) [Pubmed]
  30. Modulation of the proteolytic cascade systems by high dose corticosteroids. Aasen, A.O., Ruud, T.E., Pillgram-Larsen, J., Röise, O., Stadaas, J. Acta chirurgica Scandinavica. Supplementum. (1985) [Pubmed]
  31. Effect of immunosuppressive therapy on humoral immune response in multiple sclerosis. Wajgt, A., Górny, M., Szczechowski, L., Grzybowski, G., Ochudło, S. Acta medica Polona. (1989) [Pubmed]
  32. Successful renal transplantation in a patient with anaphylactic reaction to Solu-Medrol (methylprednisolone sodium succinate). Rao, K.V., Andersen, R.C., O'Brien, T.J. Am. J. Med. (1982) [Pubmed]
  33. Methylprednisolone sodium succinate-induced anaphylaxis in a nonatopic renal transplant recipient. John, G.T., Thomas, P.P., Kirubakaran, M.G., Thomas, M., Jacob, C.K., Shastry, J.C. Transplantation (1989) [Pubmed]
  34. Persistence, pathogenesis, and morphology of an L-form of Streptococcus pyogenes adapted to physiological isotonic conditions when in immunosuppressed mice. Fernandes, P.B., Panos, C. Infect. Immun. (1976) [Pubmed]
  35. A double-blind randomized crossover study to compare the antiemetic efficacy of 250 mg with 500 mg methylprednisolone succinate (Solu-Medrol) as a single intravenous dose in patients treated with noncisplatin chemotherapy. Pieters, R.C., Vermorken, J.B., Gall, H.E., Nauta, J.J., van Loenen, A.C., van Groeningen, C.J., van Rijswijk, R.E., Brenninkmeijer, J.H., Pinedo, H.M. Oncology (1993) [Pubmed]
WikiGenes - Universities